TY - JOUR
T1 - A Blood Drying Process for DNA Amplification
AU - Lim, Jongwon
AU - Zhou, Shuaizhen
AU - Baek, Janice
AU - Kim, Alicia Yeaeun
AU - Valera, Enrique
AU - Sweedler, Jonathan
AU - Bashir, Rashid
N1 - R.B. and E.V. acknowledge support from the Jump ARCHES (Applied Research through Community Health through Engineering and Simulation) endowment through the Health Care Engineering Systems Center at UIUC and OSF. This work was supported, in part, by the Dynamic Research Enterprise for Multidisciplinary Engineering Sciences (DREMES) Center funded by the Zhejiang University of Illinois ZJUI Joint Institute. J.L. acknowledge BioRender for the creation of figures. Figures\u00A01, 2, 4, and\u00A06 were created with BioRender.com. The authors thank the staff at the Holonyak Micro and Nanotechnology Laboratory at UIUC for facilitating the research and the funding from University of Illinois. The following agents were obtained through BEI Resources, NIAID, NIH: genomic DNA of MRSA strain HFH-30106, NR-10320, genomic DNA of E. coli (O157:H7), NR-4629, MSSA bacteria strain MN8, NR-45918.
PY - 2024/3/15
Y1 - 2024/3/15
N2 - The presence of numerous inhibitors in blood makes their use in nucleic acid amplification techniques difficult. Current methods for extracting and purifying pathogenic DNA from blood involve removal of inhibitors, resulting in low and inconsistent DNA recovery rates. To address this issue, a biphasic method is developed that simultaneously achieves inhibitor inactivation and DNA amplification without the need for a purification step. Inhibitors are physically trapped in the solid-phase dried blood matrix by blood drying, while amplification reagents can move into the solid nano-porous dried blood and initiate the amplification. It is demonstrated that the biphasic method has significant improvement in detection limits for bacteria such as Escherichia coli, Methicillin-resistant Staphylococcus aureus, Methicillin-Sensitive Staphylococcus aureus using loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA). Several factors, such as drying time, sample volume, and material properties are characterized to increase sensitivity and expand the application of the biphasic assay to blood diagnostics. With further automation, this biphasic technique has the potential to be used as a diagnostic platform for the detection of pathogens eliminating lengthy culture steps.
AB - The presence of numerous inhibitors in blood makes their use in nucleic acid amplification techniques difficult. Current methods for extracting and purifying pathogenic DNA from blood involve removal of inhibitors, resulting in low and inconsistent DNA recovery rates. To address this issue, a biphasic method is developed that simultaneously achieves inhibitor inactivation and DNA amplification without the need for a purification step. Inhibitors are physically trapped in the solid-phase dried blood matrix by blood drying, while amplification reagents can move into the solid nano-porous dried blood and initiate the amplification. It is demonstrated that the biphasic method has significant improvement in detection limits for bacteria such as Escherichia coli, Methicillin-resistant Staphylococcus aureus, Methicillin-Sensitive Staphylococcus aureus using loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA). Several factors, such as drying time, sample volume, and material properties are characterized to increase sensitivity and expand the application of the biphasic assay to blood diagnostics. With further automation, this biphasic technique has the potential to be used as a diagnostic platform for the detection of pathogens eliminating lengthy culture steps.
KW - DNA amplification
KW - blood drying
KW - blood-borne pathogens
KW - extraction and purification free amplification
KW - inhibitor inactivation
UR - http://www.scopus.com/inward/record.url?scp=85174917995&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85174917995&partnerID=8YFLogxK
U2 - 10.1002/smll.202307959
DO - 10.1002/smll.202307959
M3 - Article
C2 - 37888793
AN - SCOPUS:85174917995
SN - 1613-6810
VL - 20
JO - Small
JF - Small
IS - 11
M1 - 2307959
ER -